nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—MAOB—Parkinson's disease	0.303	0.381	CbGaD
Phentermine—MAOA—Parkinson's disease	0.213	0.267	CbGaD
Phentermine—SLC6A3—Parkinson's disease	0.183	0.23	CbGaD
Phentermine—CYP2D6—Parkinson's disease	0.0964	0.121	CbGaD
Phentermine—SLC6A2—locus ceruleus—Parkinson's disease	0.00572	0.0911	CbGeAlD
Phentermine—MAOA—locus ceruleus—Parkinson's disease	0.00527	0.0839	CbGeAlD
Phentermine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00452	0.072	CbGeAlD
Phentermine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00336	0.0535	CbGeAlD
Phentermine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00304	0.0484	CbGeAlD
Phentermine—SLC6A3—nerve—Parkinson's disease	0.00212	0.0337	CbGeAlD
Phentermine—MAOB—nerve—Parkinson's disease	0.00185	0.0294	CbGeAlD
Phentermine—SLC6A2—nerve—Parkinson's disease	0.00171	0.0272	CbGeAlD
Phentermine—SLC6A3—hindbrain—Parkinson's disease	0.00159	0.0253	CbGeAlD
Phentermine—MAOA—nerve—Parkinson's disease	0.00158	0.0251	CbGeAlD
Phentermine—SLC6A4—hindbrain—Parkinson's disease	0.00146	0.0232	CbGeAlD
Phentermine—MAOB—hindbrain—Parkinson's disease	0.00138	0.022	CbGeAlD
Phentermine—MAOA—hindbrain—Parkinson's disease	0.00118	0.0188	CbGeAlD
Phentermine—SLC6A3—brainstem—Parkinson's disease	0.00091	0.0145	CbGeAlD
Phentermine—SLC6A3—forebrain—Parkinson's disease	0.000878	0.014	CbGeAlD
Phentermine—MAOB—embryo—Parkinson's disease	0.000865	0.0138	CbGeAlD
Phentermine—SLC6A4—brainstem—Parkinson's disease	0.000834	0.0133	CbGeAlD
Phentermine—SLC6A4—forebrain—Parkinson's disease	0.000805	0.0128	CbGeAlD
Phentermine—MAOB—brainstem—Parkinson's disease	0.000793	0.0126	CbGeAlD
Phentermine—MAOB—forebrain—Parkinson's disease	0.000765	0.0122	CbGeAlD
Phentermine—MAOA—embryo—Parkinson's disease	0.000738	0.0117	CbGeAlD
Phentermine—SLC6A2—brainstem—Parkinson's disease	0.000734	0.0117	CbGeAlD
Phentermine—SLC6A2—forebrain—Parkinson's disease	0.000709	0.0113	CbGeAlD
Phentermine—CYP2D6—hindbrain—Parkinson's disease	0.000701	0.0112	CbGeAlD
Phentermine—MAOA—brainstem—Parkinson's disease	0.000676	0.0108	CbGeAlD
Phentermine—MAOA—forebrain—Parkinson's disease	0.000653	0.0104	CbGeAlD
Phentermine—MAOB—cardiovascular system—Parkinson's disease	0.000647	0.0103	CbGeAlD
Phentermine—SLC6A3—midbrain—Parkinson's disease	0.00058	0.00923	CbGeAlD
Phentermine—SLC6A3—spinal cord—Parkinson's disease	0.000566	0.009	CbGeAlD
Phentermine—MAOB—medulla oblongata—Parkinson's disease	0.000553	0.0088	CbGeAlD
Phentermine—MAOA—cardiovascular system—Parkinson's disease	0.000552	0.00878	CbGeAlD
Phentermine—SLC6A4—midbrain—Parkinson's disease	0.000531	0.00846	CbGeAlD
Phentermine—SLC6A4—spinal cord—Parkinson's disease	0.000519	0.00825	CbGeAlD
Phentermine—SLC6A2—medulla oblongata—Parkinson's disease	0.000512	0.00815	CbGeAlD
Phentermine—MAOB—midbrain—Parkinson's disease	0.000505	0.00804	CbGeAlD
Phentermine—SLC6A3—head—Parkinson's disease	0.000503	0.008	CbGeAlD
Phentermine—MAOB—spinal cord—Parkinson's disease	0.000493	0.00784	CbGeAlD
Phentermine—Pargyline—MAOB—Parkinson's disease	0.000489	0.0686	CrCbGaD
Phentermine—Ephedrine—SLC18A2—Parkinson's disease	0.000481	0.0675	CrCbGaD
Phentermine—SLC6A3—nervous system—Parkinson's disease	0.000477	0.00759	CbGeAlD
Phentermine—MAOA—medulla oblongata—Parkinson's disease	0.000472	0.00751	CbGeAlD
Phentermine—SLC6A4—head—Parkinson's disease	0.000461	0.00733	CbGeAlD
Phentermine—SLC6A3—central nervous system—Parkinson's disease	0.000459	0.0073	CbGeAlD
Phentermine—SLC6A3—cerebellum—Parkinson's disease	0.000449	0.00714	CbGeAlD
Phentermine—MAOB—head—Parkinson's disease	0.000438	0.00697	CbGeAlD
Phentermine—CYP2C9—cardiovascular system—Parkinson's disease	0.000437	0.00696	CbGeAlD
Phentermine—SLC6A4—nervous system—Parkinson's disease	0.000437	0.00695	CbGeAlD
Phentermine—MAOA—midbrain—Parkinson's disease	0.000431	0.00686	CbGeAlD
Phentermine—SLC6A4—central nervous system—Parkinson's disease	0.000421	0.00669	CbGeAlD
Phentermine—MAOA—spinal cord—Parkinson's disease	0.000421	0.00669	CbGeAlD
Phentermine—MAOB—nervous system—Parkinson's disease	0.000415	0.00661	CbGeAlD
Phentermine—SLC6A2—head—Parkinson's disease	0.000406	0.00646	CbGeAlD
Phentermine—CYP2D6—brainstem—Parkinson's disease	0.000402	0.0064	CbGeAlD
Phentermine—MAOB—central nervous system—Parkinson's disease	0.0004	0.00636	CbGeAlD
Phentermine—MAOB—cerebellum—Parkinson's disease	0.000391	0.00622	CbGeAlD
Phentermine—CYP2D6—forebrain—Parkinson's disease	0.000388	0.00617	CbGeAlD
Phentermine—SLC6A2—nervous system—Parkinson's disease	0.000385	0.00612	CbGeAlD
Phentermine—MAOA—head—Parkinson's disease	0.000374	0.00595	CbGeAlD
Phentermine—SLC6A2—central nervous system—Parkinson's disease	0.00037	0.00589	CbGeAlD
Phentermine—Dextroamphetamine—SLC18A2—Parkinson's disease	0.000367	0.0515	CrCbGaD
Phentermine—SLC6A3—brain—Parkinson's disease	0.000364	0.0058	CbGeAlD
Phentermine—MAOA—nervous system—Parkinson's disease	0.000354	0.00564	CbGeAlD
Phentermine—L-Phenylalanine—TH—Parkinson's disease	0.000346	0.0486	CrCbGaD
Phentermine—Pargyline—MAOA—Parkinson's disease	0.000343	0.0481	CrCbGaD
Phentermine—MAOA—central nervous system—Parkinson's disease	0.000341	0.00543	CbGeAlD
Phentermine—SLC6A4—brain—Parkinson's disease	0.000334	0.00531	CbGeAlD
Phentermine—MAOA—cerebellum—Parkinson's disease	0.000334	0.00531	CbGeAlD
Phentermine—MAOB—brain—Parkinson's disease	0.000318	0.00505	CbGeAlD
Phentermine—Tranylcypromine—MAOB—Parkinson's disease	0.000315	0.0442	CrCbGaD
Phentermine—Amphetamine—SLC18A2—Parkinson's disease	0.000296	0.0415	CrCbGaD
Phentermine—SLC6A2—brain—Parkinson's disease	0.000294	0.00468	CbGeAlD
Phentermine—Methamphetamine—SLC18A2—Parkinson's disease	0.000274	0.0385	CrCbGaD
Phentermine—MAOA—brain—Parkinson's disease	0.000271	0.00431	CbGeAlD
Phentermine—Selegiline—MAOB—Parkinson's disease	0.000244	0.0343	CrCbGaD
Phentermine—CYP2D6—head—Parkinson's disease	0.000222	0.00354	CbGeAlD
Phentermine—Tranylcypromine—MAOA—Parkinson's disease	0.000221	0.031	CrCbGaD
Phentermine—Phenelzine—MAOB—Parkinson's disease	0.000215	0.0302	CrCbGaD
Phentermine—CYP2D6—nervous system—Parkinson's disease	0.000211	0.00335	CbGeAlD
Phentermine—Phenylpropanolamine—MAOA—Parkinson's disease	0.000208	0.0291	CrCbGaD
Phentermine—Amphetamine—MAOB—Parkinson's disease	0.000203	0.0285	CrCbGaD
Phentermine—CYP2D6—central nervous system—Parkinson's disease	0.000203	0.00323	CbGeAlD
Phentermine—CYP2D6—cerebellum—Parkinson's disease	0.000198	0.00315	CbGeAlD
Phentermine—Phenylpropanolamine—DRD1—Parkinson's disease	0.000189	0.0265	CrCbGaD
Phentermine—Methamphetamine—MAOB—Parkinson's disease	0.000188	0.0264	CrCbGaD
Phentermine—Phenylpropanolamine—SLC6A3—Parkinson's disease	0.000179	0.0251	CrCbGaD
Phentermine—Pseudoephedrine—MAOA—Parkinson's disease	0.000175	0.0246	CrCbGaD
Phentermine—Selegiline—MAOA—Parkinson's disease	0.000171	0.024	CrCbGaD
Phentermine—CYP2D6—brain—Parkinson's disease	0.000161	0.00256	CbGeAlD
Phentermine—Dextroamphetamine—SLC6A3—Parkinson's disease	0.000152	0.0214	CrCbGaD
Phentermine—Pseudoephedrine—SLC6A3—Parkinson's disease	0.000151	0.0212	CrCbGaD
Phentermine—Phenelzine—MAOA—Parkinson's disease	0.000151	0.0212	CrCbGaD
Phentermine—Pseudoephedrine—TNF—Parkinson's disease	0.000141	0.0197	CrCbGaD
Phentermine—Tranylcypromine—CYP2E1—Parkinson's disease	0.000136	0.0191	CrCbGaD
Phentermine—Methamphetamine—MAOA—Parkinson's disease	0.000132	0.0185	CrCbGaD
Phentermine—Amphetamine—SLC6A3—Parkinson's disease	0.000123	0.0172	CrCbGaD
Phentermine—Phenformin—CYP2D6—Parkinson's disease	0.000123	0.0172	CrCbGaD
Phentermine—Methamphetamine—SLC6A3—Parkinson's disease	0.000114	0.016	CrCbGaD
Phentermine—Benzyl alcohol—CYP2E1—Parkinson's disease	0.00011	0.0155	CrCbGaD
Phentermine—Selegiline—CYP2E1—Parkinson's disease	0.000106	0.0148	CrCbGaD
Phentermine—Tranylcypromine—CYP2D6—Parkinson's disease	0.0001	0.014	CrCbGaD
Phentermine—Phenelzine—CYP2E1—Parkinson's disease	9.31e-05	0.0131	CrCbGaD
Phentermine—Amphetamine—DRD2—Parkinson's disease	9.12e-05	0.0128	CrCbGaD
Phentermine—Benzyl alcohol—CYP2D6—Parkinson's disease	8.09e-05	0.0113	CrCbGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	8.08e-05	0.000602	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—COMT—Parkinson's disease	8.04e-05	0.000598	CbGpPWpGaD
Phentermine—Dextroamphetamine—CYP2D6—Parkinson's disease	8e-05	0.0112	CrCbGaD
Phentermine—MAOA—Biological oxidations—GSTP1—Parkinson's disease	8e-05	0.000595	CbGpPWpGaD
Phentermine—Pseudoephedrine—CYP2D6—Parkinson's disease	7.95e-05	0.0112	CrCbGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	7.95e-05	0.000592	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	7.9e-05	0.000588	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	7.88e-05	0.000586	CbGpPWpGaD
Phentermine—MAOB—Metabolism—TALDO1—Parkinson's disease	7.81e-05	0.000581	CbGpPWpGaD
Phentermine—MAOB—Metabolism—OMD—Parkinson's disease	7.81e-05	0.000581	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GSTM1—Parkinson's disease	7.79e-05	0.00058	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—HGF—Parkinson's disease	7.79e-05	0.00058	CbGpPWpGaD
Phentermine—Selegiline—CYP2D6—Parkinson's disease	7.76e-05	0.0109	CrCbGaD
Phentermine—MAOA—Neuronal System—CHRNA4—Parkinson's disease	7.74e-05	0.000576	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NDUFB11—Parkinson's disease	7.4e-05	0.000551	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—NGF—Parkinson's disease	7.39e-05	0.00055	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	7.36e-05	0.000548	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—GSTM1—Parkinson's disease	7.35e-05	0.000547	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—CHRNA4—Parkinson's disease	7.2e-05	0.000536	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	7.12e-05	0.00053	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—COMT—Parkinson's disease	7.12e-05	0.00053	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—HSPA8—Parkinson's disease	7.1e-05	0.000528	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GCH1—Parkinson's disease	7.06e-05	0.000526	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	7.03e-05	0.000523	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	6.97e-05	0.000519	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	6.97e-05	0.000519	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	6.91e-05	0.000514	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	6.87e-05	0.000512	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	6.81e-05	0.000507	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	6.73e-05	0.000501	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—DLG4—Parkinson's disease	6.66e-05	0.000496	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—COMT—Parkinson's disease	6.62e-05	0.000493	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—HSPA8—Parkinson's disease	6.6e-05	0.000491	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.57e-05	0.000489	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.54e-05	0.000487	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—GRIN2B—Parkinson's disease	6.51e-05	0.000485	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.48e-05	0.000482	CbGpPWpGaD
Phentermine—Amphetamine—CYP2D6—Parkinson's disease	6.45e-05	0.00905	CrCbGaD
Phentermine—MAOA—Neuronal System—SLC6A3—Parkinson's disease	6.42e-05	0.000478	CbGpPWpGaD
Phentermine—MAOB—Metabolism—FBP1—Parkinson's disease	6.29e-05	0.000468	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GBA—Parkinson's disease	6.29e-05	0.000468	CbGpPWpGaD
Phentermine—MAOB—Metabolism—DBH—Parkinson's disease	6.29e-05	0.000468	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	6.21e-05	0.000462	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—DLG4—Parkinson's disease	6.19e-05	0.000461	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	6.16e-05	0.000458	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—GRIN2B—Parkinson's disease	6.05e-05	0.00045	CbGpPWpGaD
Phentermine—Methamphetamine—CYP2D6—Parkinson's disease	5.97e-05	0.00839	CrCbGaD
Phentermine—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	5.9e-05	0.000439	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	5.82e-05	0.000433	CbGpPWpGaD
Phentermine—Selegiline—ABCB1—Parkinson's disease	5.54e-05	0.00778	CrCbGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.54e-05	0.000412	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.52e-05	0.000411	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—COMT—Parkinson's disease	5.46e-05	0.000406	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	5.26e-05	0.000392	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ND3—Parkinson's disease	5.21e-05	0.000388	CbGpPWpGaD
Phentermine—MAOA—Metabolism—MCCC1—Parkinson's disease	5.21e-05	0.000388	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.08e-05	0.000378	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—CP—Parkinson's disease	5.08e-05	0.000378	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.07e-05	0.000378	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—COMT—Parkinson's disease	5.07e-05	0.000377	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	5.07e-05	0.000377	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	5.04e-05	0.000375	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—MAOA—Parkinson's disease	5.04e-05	0.000375	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TALDO1—Parkinson's disease	4.9e-05	0.000365	CbGpPWpGaD
Phentermine—MAOA—Metabolism—OMD—Parkinson's disease	4.9e-05	0.000365	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.89e-05	0.000364	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NDUFB11—Parkinson's disease	4.64e-05	0.000346	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	4.63e-05	0.000345	CbGpPWpGaD
Phentermine—MAOB—Metabolism—DDC—Parkinson's disease	4.62e-05	0.000344	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	4.58e-05	0.000341	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.51e-05	0.000336	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—CP—Parkinson's disease	4.5e-05	0.000335	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GCH1—Parkinson's disease	4.43e-05	0.00033	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTA4—Parkinson's disease	4.36e-05	0.000325	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	4.22e-05	0.000314	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	4.19e-05	0.000312	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	4.17e-05	0.00031	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.16e-05	0.00031	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	4.16e-05	0.00031	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.13e-05	0.000307	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	4.08e-05	0.000304	CbGpPWpGaD
Phentermine—MAOA—Metabolism—FBP1—Parkinson's disease	3.95e-05	0.000294	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GBA—Parkinson's disease	3.95e-05	0.000294	CbGpPWpGaD
Phentermine—MAOA—Metabolism—DBH—Parkinson's disease	3.95e-05	0.000294	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PLA2G6—Parkinson's disease	3.93e-05	0.000292	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	3.91e-05	0.000291	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.86e-05	0.000287	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.83e-05	0.000285	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—MAPK8—Parkinson's disease	3.81e-05	0.000283	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.69e-05	0.000275	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.62e-05	0.000269	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	3.58e-05	0.000266	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.53e-05	0.000263	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	3.5e-05	0.00026	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	3.48e-05	0.000259	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.48e-05	0.000259	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	3.47e-05	0.000259	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—COMT—Parkinson's disease	3.47e-05	0.000258	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	3.45e-05	0.000257	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	3.45e-05	0.000257	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	3.44e-05	0.000256	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	3.43e-05	0.000256	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	3.42e-05	0.000255	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	3.4e-05	0.000253	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.27e-05	0.000243	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	3.2e-05	0.000238	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	3.17e-05	0.000236	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	3.16e-05	0.000235	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	3.13e-05	0.000233	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.08e-05	0.000229	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.02e-05	0.000225	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.02e-05	0.000225	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.98e-05	0.000222	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	2.96e-05	0.000221	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	2.96e-05	0.000221	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	2.96e-05	0.000221	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	2.95e-05	0.00022	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	2.94e-05	0.000219	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	2.92e-05	0.000218	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	2.91e-05	0.000217	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.9e-05	0.000216	CbGpPWpGaD
Phentermine—MAOA—Metabolism—DDC—Parkinson's disease	2.9e-05	0.000216	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP2D6—Parkinson's disease	2.89e-05	0.000215	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CTGF—Parkinson's disease	2.84e-05	0.000211	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTA4—Parkinson's disease	2.74e-05	0.000204	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	2.71e-05	0.000202	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.68e-05	0.000199	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	2.67e-05	0.000199	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP2E1—Parkinson's disease	2.64e-05	0.000197	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NQO1—Parkinson's disease	2.61e-05	0.000195	CbGpPWpGaD
Phentermine—MAOB—Metabolism—TH—Parkinson's disease	2.58e-05	0.000192	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.57e-05	0.000191	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYCS—Parkinson's disease	2.47e-05	0.000184	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PLA2G6—Parkinson's disease	2.46e-05	0.000183	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.44e-05	0.000182	CbGpPWpGaD
Phentermine—MAOA—Metabolism—MAOB—Parkinson's disease	2.44e-05	0.000182	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	2.43e-05	0.000181	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.39e-05	0.000178	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ND3—Parkinson's disease	2.27e-05	0.000169	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.27e-05	0.000169	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	2.25e-05	0.000167	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ND3—Parkinson's disease	2.25e-05	0.000167	CbGpPWpGaD
Phentermine—MAOB—Metabolism—COMT—Parkinson's disease	2.19e-05	0.000163	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTP1—Parkinson's disease	2.18e-05	0.000162	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MAOA—Parkinson's disease	2.17e-05	0.000162	CbGpPWpGaD
Phentermine—MAOB—Metabolism—HMOX1—Parkinson's disease	2.15e-05	0.00016	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.13e-05	0.000159	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—OMD—Parkinson's disease	2.13e-05	0.000159	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	2.11e-05	0.000157	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—OMD—Parkinson's disease	2.11e-05	0.000157	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ABCB1—Parkinson's disease	2.06e-05	0.000154	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.04e-05	0.000152	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.02e-05	0.00015	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	2e-05	0.000149	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTM1—Parkinson's disease	2e-05	0.000149	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.93e-05	0.000144	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	1.92e-05	0.000143	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ND3—Parkinson's disease	1.92e-05	0.000143	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GPX1—Parkinson's disease	1.92e-05	0.000143	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GCH1—Parkinson's disease	1.91e-05	0.000142	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP2D6—Parkinson's disease	1.81e-05	0.000135	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	1.81e-05	0.000134	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—OMD—Parkinson's disease	1.81e-05	0.000134	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CTGF—Parkinson's disease	1.78e-05	0.000132	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MTHFR—Parkinson's disease	1.77e-05	0.000132	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.72e-05	0.000128	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.72e-05	0.000128	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.72e-05	0.000128	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.72e-05	0.000128	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	1.71e-05	0.000127	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—DBH—Parkinson's disease	1.7e-05	0.000127	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GBA—Parkinson's disease	1.7e-05	0.000127	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—FBP1—Parkinson's disease	1.7e-05	0.000127	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP2E1—Parkinson's disease	1.66e-05	0.000123	CbGpPWpGaD
Phentermine—MAOB—Metabolism—APOE—Parkinson's disease	1.65e-05	0.000123	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NQO1—Parkinson's disease	1.64e-05	0.000122	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GCH1—Parkinson's disease	1.63e-05	0.000122	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TH—Parkinson's disease	1.62e-05	0.00012	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYCS—Parkinson's disease	1.55e-05	0.000115	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.47e-05	0.00011	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GBA—Parkinson's disease	1.46e-05	0.000108	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.46e-05	0.000108	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—DBH—Parkinson's disease	1.46e-05	0.000108	CbGpPWpGaD
Phentermine—MAOB—Metabolism—INS—Parkinson's disease	1.41e-05	0.000105	CbGpPWpGaD
Phentermine—MAOA—Metabolism—COMT—Parkinson's disease	1.37e-05	0.000102	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTP1—Parkinson's disease	1.37e-05	0.000102	CbGpPWpGaD
Phentermine—MAOA—Metabolism—HMOX1—Parkinson's disease	1.35e-05	0.0001	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ABCB1—Parkinson's disease	1.29e-05	9.64e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.26e-05	9.39e-05	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTM1—Parkinson's disease	1.26e-05	9.35e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—DDC—Parkinson's disease	1.25e-05	9.31e-05	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GPX1—Parkinson's disease	1.2e-05	8.96e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.19e-05	8.87e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.18e-05	8.79e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.17e-05	8.68e-05	CbGpPWpGaD
Phentermine—MAOA—Metabolism—MTHFR—Parkinson's disease	1.11e-05	8.27e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.07e-05	7.99e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—DDC—Parkinson's disease	1.07e-05	7.96e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.06e-05	7.92e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.06e-05	7.91e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.05e-05	7.84e-05	CbGpPWpGaD
Phentermine—MAOA—Metabolism—APOE—Parkinson's disease	1.03e-05	7.7e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.01e-05	7.51e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1e-05	7.46e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.97e-06	7.42e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	9.09e-06	6.77e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MAOB—Parkinson's disease	9e-06	6.7e-05	CbGpPWpGaD
Phentermine—MAOA—Metabolism—INS—Parkinson's disease	8.83e-06	6.58e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.56e-06	6.37e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	7.83e-06	5.82e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CTGF—Parkinson's disease	7.75e-06	5.77e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CTGF—Parkinson's disease	7.68e-06	5.72e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	7.22e-06	5.37e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	7.16e-06	5.33e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NQO1—Parkinson's disease	7.14e-06	5.31e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NQO1—Parkinson's disease	7.08e-06	5.27e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TH—Parkinson's disease	7.04e-06	5.24e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TH—Parkinson's disease	6.97e-06	5.19e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYCS—Parkinson's disease	6.76e-06	5.03e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYCS—Parkinson's disease	6.7e-06	4.98e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	6.69e-06	4.98e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CTGF—Parkinson's disease	6.56e-06	4.89e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	6.12e-06	4.55e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NQO1—Parkinson's disease	6.05e-06	4.5e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—COMT—Parkinson's disease	5.98e-06	4.45e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TH—Parkinson's disease	5.96e-06	4.44e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	5.95e-06	4.43e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MAOA—Parkinson's disease	5.94e-06	4.42e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—COMT—Parkinson's disease	5.93e-06	4.41e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	5.9e-06	4.39e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MAOA—Parkinson's disease	5.89e-06	4.38e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	5.87e-06	4.37e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	5.82e-06	4.33e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYCS—Parkinson's disease	5.72e-06	4.26e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	5.64e-06	4.2e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	5.59e-06	4.16e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	5.47e-06	4.07e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	5.42e-06	4.04e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.24e-06	3.9e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GPX1—Parkinson's disease	5.19e-06	3.87e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—COMT—Parkinson's disease	5.07e-06	3.77e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	5.04e-06	3.75e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MAOA—Parkinson's disease	5.03e-06	3.75e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.97e-06	3.7e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	4.84e-06	3.6e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	4.79e-06	3.57e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	4.77e-06	3.55e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	4.64e-06	3.45e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—APOE—Parkinson's disease	4.5e-06	3.35e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—APOE—Parkinson's disease	4.46e-06	3.32e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GPX1—Parkinson's disease	4.44e-06	3.3e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	4.1e-06	3.05e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—INS—Parkinson's disease	3.85e-06	2.86e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—APOE—Parkinson's disease	3.81e-06	2.84e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—INS—Parkinson's disease	3.81e-06	2.84e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—INS—Parkinson's disease	3.26e-06	2.42e-05	CbGpPWpGaD
